BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17172671)

  • 1. Long-term gene expression in dividing and nondividing cells using SV40-derived vectors.
    Strayer DS; Agrawal L; Cordelier P; Liu B; Louboutin JP; Marusich E; McKee HJ; Ren CN; Strayer MS
    Mol Biotechnol; 2006 Oct; 34(2):257-70. PubMed ID: 17172671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors.
    Strayer D; Branco F; Zern MA; Yam P; Calarota SA; Nichols CN; Zaia JA; Rossi J; Li H; Parashar B; Ghosh S; Chowdhury JR
    Mol Ther; 2002 Aug; 6(2):227-37. PubMed ID: 12161189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.
    Strayer DS; Pomerantz RJ; Yu M; Rosenzweig M; BouHamdan M; Yurasov S; Johnson RP; Goldstein H
    Gene Ther; 2000 May; 7(10):886-95. PubMed ID: 10845727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer to the rhesus monkey brain using SV40-derived vectors is durable and safe.
    Louboutin JP; Marusich E; Fisher-Perkins J; Dufour JP; Bunnell BA; Strayer DS
    Gene Ther; 2011 Jul; 18(7):682-91. PubMed ID: 21368898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy using SV40-derived vectors: what does the future hold?
    Strayer DS
    J Cell Physiol; 1999 Dec; 181(3):375-84. PubMed ID: 10528223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors.
    Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele E; Strayer DS
    Gene Ther; 2007 Jun; 14(12):939-49. PubMed ID: 17443215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
    Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
    Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SV40-based gene therapy vectors: turning an adversary into a friend.
    Strayer DS
    Curr Opin Mol Ther; 2000 Oct; 2(5):570-8. PubMed ID: 11249759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo gene transfer into rat bone marrow progenitor cells using rSV40 viral vectors.
    Liu B; Daviau J; Nichols CN; Strayer DS
    Blood; 2005 Oct; 106(8):2655-62. PubMed ID: 15994284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simian virus-40 as a gene therapy vector.
    Vera M; Fortes P
    DNA Cell Biol; 2004 May; 23(5):271-82. PubMed ID: 15169607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-targeted gene therapy by SV40-based vectors using the hydrodynamic injection method.
    Arad U; Zeira E; El-Latif MA; Mukherjee S; Mitchell L; Pappo O; Galun E; Oppenheim A
    Hum Gene Ther; 2005 Mar; 16(3):361-71. PubMed ID: 15812231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of SV40-derived vectors.
    Strayer DS; Mitchell C; Maier DA; Nichols CN
    Cold Spring Harb Protoc; 2010 Jun; 2010(6):pdb.prot5436. PubMed ID: 20516174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What they are, how they work and why they do what they do? The story of SV40-derived gene therapy vectors and what they have to offer.
    Strayer DS; Cordelier P; Kondo R; Liu B; Matskevich AA; McKee HJ; Nichols CN; Mitchell CB; Geverd DA; White MK; Strayer MS
    Curr Gene Ther; 2005 Apr; 5(2):151-65. PubMed ID: 15853724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient CNS gene delivery by intravenous injection.
    Louboutin JP; Chekmasova AA; Marusich E; Chowdhury JR; Strayer DS
    Nat Methods; 2010 Nov; 7(11):905-7. PubMed ID: 20953176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination genetic therapy to inhibit HIV-1.
    Strayer DS; Branco F; Landré J; BouHamdan M; Shaheen F; Pomerantz RJ
    Mol Ther; 2002 Jan; 5(1):33-41. PubMed ID: 11786043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo gene transfer to the CNS using recombinant SV40-derived vectors.
    Louboutin JP; Agrawal L; Liu B; Strayer DS
    Expert Opin Biol Ther; 2008 Sep; 8(9):1319-35. PubMed ID: 18694352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What can SV40-derived vectors do for gene therapy?
    Strayer DS; Zern MA; Chowdhury JR
    Curr Opin Mol Ther; 2002 Aug; 4(4):313-23. PubMed ID: 12222869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer to the cerebellum.
    Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
    Cerebellum; 2010 Dec; 9(4):587-97. PubMed ID: 20700772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIV.
    Cordelier P; Morse B; Strayer DS
    Oligonucleotides; 2003; 13(5):281-94. PubMed ID: 15000819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus-based vectors in gene therapy.
    Tal J
    J Biomed Sci; 2000; 7(4):279-91. PubMed ID: 10895050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.